News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,120 Results
Type
Article (13620)
Company Profile (110)
Press Release (248390)
Section
Business (87982)
Career Advice (464)
Deals (15331)
Drug Delivery (64)
Drug Development (36546)
Employer Resources (49)
FDA (6265)
Job Trends (6198)
News (150091)
Policy (14012)
Tag
Academia (436)
Alliances (23147)
Alzheimer's disease (361)
Approvals (6270)
Artificial intelligence (67)
Bankruptcy (143)
Best Places to Work (4359)
Biotechnology (44)
Breast cancer (60)
Cancer (399)
Career advice (406)
Cell therapy (56)
Clinical research (30554)
Collaboration (194)
Compensation (79)
COVID-19 (748)
C-suite (58)
Data (425)
Diabetes (59)
Diagnostics (1241)
Drug pricing (59)
Earnings (31584)
Employer resources (43)
Events (36899)
Executive appointments (218)
FDA (6488)
Funding (128)
Gene therapy (62)
GLP-1 (302)
Government (1270)
Healthcare (3531)
Infectious disease (768)
Inflammatory bowel disease (49)
Interviews (58)
IPO (5833)
Job creations (2050)
Job search strategy (372)
Layoffs (168)
Legal (3413)
Lung cancer (55)
Manufacturing (110)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9567)
Metabolic disorders (186)
Neuroscience (472)
NextGen Class of 2024 (1580)
Non-profit (592)
Northern California (491)
Obesity (109)
Opinion (112)
Patents (63)
People (28557)
Pharmaceutical (68)
Phase I (7949)
Phase II (12925)
Phase III (11606)
Pipeline (197)
Policy (46)
Postmarket research (1400)
Preclinical (3179)
Radiopharmaceuticals (116)
Rare diseases (106)
Real estate (2631)
Regulatory (9879)
Research institute (563)
Resumes & cover letters (55)
Southern California (488)
Startups (1626)
United States (4831)
Vaccines (114)
Weight loss (82)
Date
Last 7 days (222)
Last 30 days (789)
Last 365 days (12477)
2024 (12426)
2023 (14250)
2022 (19567)
2021 (20080)
2020 (19039)
2019 (14892)
2018 (11714)
2017 (13889)
2016 (13130)
2015 (15474)
2014 (12419)
2013 (10592)
2012 (11397)
2011 (11923)
2010 (10889)
Location
Africa (312)
Arizona (43)
Asia (19867)
Australia (2565)
California (1154)
Canada (671)
China (137)
Colorado (46)
Connecticut (47)
Europe (38908)
Florida (180)
Illinois (133)
Indiana (95)
Japan (51)
Kansas (51)
Maryland (171)
Massachusetts (987)
Minnesota (64)
New Jersey (494)
New York (321)
North Carolina (292)
Northern California (491)
Pennsylvania (312)
South America (498)
Southern California (488)
Texas (159)
Virginia (45)
Washington State (78)
262,120 Results for "recursion pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuroscience
Recursion Reports Thin Mid-Stage Efficacy Data for Rare Brain Disease Therapy
Recursion’s oral drug candidate for cerebral cavernous malformation showed no improvements in patient- or physician-reported outcomes at 12 months. The biotech will engage with the FDA to determine the need for an additional study.
September 4, 2024
·
2 min read
·
Tristan Manalac
Biotech Bay
Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data
Helix, a leading population genomics company and provider of precision medicine genomics solutions, announced a groundbreaking multi-year agreement with Recursion Pharmaceuticals, a leading clinical-stage TechBio company decoding biology to industrialize drug discovery.
June 24, 2024
·
2 min read
Press Releases
Angle PLC Announces Agreement with Recursion Pharmaceuticals
September 19, 2024
·
2 min read
Press Releases
Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
November 7, 2024
·
17 min read
Business
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, reported business updates and financial results for its first quarter ending March 31, 2024.
May 9, 2024
·
15 min read
Business
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Recursion announced Najat Khan, PhD, will be its Chief R&D Officer and Chief Commercial Officer.
April 16, 2024
·
5 min read
Business
Recursion Announces Plans to Open New Office in London
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced plans to open a new office in London’s vibrant King’s Cross neighborhood.
March 11, 2024
·
6 min read
Press Releases
Recursion Reports Interim Phase 1 Clinical Data for REC-617 Monotherapy, a Potential Best-in-Class CDK7 Inhibitor, With Encouraging Patient Response and Favorable Tolerability
December 9, 2024
·
9 min read
Mergers & acquisitions
Recursion, Exscientia Merge to Create AI-Enabled Biotech
Armed with a combined $850 million in cash, the companies said Thursday the resulting biotech will have a pipeline that could deliver 10 clinical readouts over the next 18 months.
August 8, 2024
·
2 min read
·
Nick Paul Taylor
Press Releases
Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma
December 3, 2024
·
6 min read
1 of 26,212
Next
